TAMOXIFEN CITRATE
Generic: TAMOXIFEN CITRATE
Aurobindo Pharma LimitedManufacturer
ORALRoute
TAMOXIFEN CITRATEActive Substance
2020-08-14Original Approval
TAMOXIFEN CITRATE is FDA application ANDA213358, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FATIGUE
387 reports
2
NAUSEA
346 reports
3
ARTHRALGIA
274 reports
4
DIARRHOEA
271 reports
5
MALIGNANT NEOPLASM PROGRESSION
265 reports
6
PAIN
243 reports
7
VOMITING
224 reports
8
DYSPNOEA
221 reports
9
BREAST CANCER
219 reports
10
DIZZINESS
213 reports